📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

B cell depletion with rituximab in the treatment of primary Sjögren's syndrome: what have we learnt? (2019)

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 31464681

Publication URI: http://europepmc.org/abstract/MED/31464681

Type: Journal Article/Review

Volume: 37 Suppl 118

Parent Publication: Clinical and experimental rheumatology

Issue: 3

ISSN: 0392-856X